-
Reputation and Its Risks
Public relations Magazine ArticleIdentify, quantify, and manage the risks to your company’s reputation long before a problem or crisis strikes. -
Ending the War Between Sales and Marketing
Business communication Magazine ArticleIn many companies, sales forces and marketers feud like Capulets and Montagues—with disastrous results. Here’s how to get them to lay down their swords. -
Who Has the D?: How Clear Decision Roles Enhance Organizational Performance
Decision making and problem solving Magazine ArticleYour organization can become more decisive—and can implement strategy more quickly—if you know where the bottlenecks are and who’s empowered to break through them. -
3 Business Models That Could Bring Million-Dollar Cures to Everyone
Innovation Digital ArticleGene therapy is a medical breakthrough, but today it’s prohibitively expensive. -
Tilray's CEO on Becoming the First Mover in a Controversial Industry
Strategy & Execution Magazine ArticleThe author was working at a Silicon Valley bank in 2010 when some entrepreneurs pitched him on a "medical-cannabis technology company." He didn't know... -
How Much Cash Does Your Company Need?
Finance & Accounting Magazine ArticleIn late 2001, the directors of Pfizer asked that very question. And with good reason. After its 2000 merger with rival Warner-Lambert, the New York-based... -
The View from the Field
Sales and marketing Magazine ArticleSix leaders offer their perspectives on sales success. -
Who Goes, Who Stays? (HBR Case Study and Commentary)
Leadership & Managing People Magazine ArticleThe merger announcement between DeWaal Pharmaceuticals and BioHealth Labs was front-page news. Two months later, the press had moved on to a new story,... -
A More Rational Approach to New-Product Development
Innovation & Entrepreneurship Magazine ArticleCompanies often treat new-product development as a monolithic process, but it can be more rationally divided into two parts: an early stage that focuses... -
Putting Customers in the “Wish Mode”
Customer experience Magazine ArticleDon’t settle for just making your product better. Let your customers make it great. -
How Merck Is Trying to Keep Disrupters at Bay
Innovation & Leadership Digital ArticleInnovation isn't just about new products. -
The CEO of Novartis on Growing After a Patent Cliff
Leadership & Managing People Magazine ArticleWhen Joseph Jimenez joined Novartis, in 2007, the company was facing a big challenge: Its blockbuster drug Diovan, which accounted for more than 20% of... -
All Strategy Is Local
Strategy & Execution Magazine ArticleThe aim of strategy is to master a market environment by understanding and anticipating the actions of other economic agents, especially competitors.... -
Making Local Knowledge Global (HBR Case Study and Commentary)
Sales & Marketing Magazine ArticleDavid Martin, chief operating officer of Lexington Labs, was apprehensive about the upcoming meeting with his senior sales executives. Just a few years... -
Managing Authenticity: The Paradox of Great Leadership
Leadership & Managing People Magazine ArticleLeaders and followers both associate authenticity with sincerity, honesty, and integrity. It's the real thing--the attribute that uniquely defines great... -
New Logic of High-Tech R&D
Technology & Operations Magazine ArticleFew managers of high-technology companies view manufacturing as a primary souce of competitive advantage. Indeed, companies in high-tech industries increasingly... -
Local Memoirs of a Global Manager
International business Magazine ArticleManaging in my homeland taught me to treasure the provincial as well as the universal. -
Innovating for Cash
Technology & Operations Magazine ArticleReprint: R0309E Despite companies' almost fanatical worship of innovation, most new products don't generate money. That's because executives don't realize... -
When Should a Leader Apologize—and When Not?
Business communication Magazine ArticleFor a leader, a public apology is always a high-risk move. Understanding what apologies can and cannot do will help you avoid both foolhardy stonewalling and unnecessary contrition. -
Biogen Unchained
Marketing Magazine ArticleWhen the biotech pioneer had to get a blockbuster drug to market fast, it didn’t lock itself into a rigid supply chain. It joined with partners to become a virtual manufacturer.
-
Sarva Pharmaceuticals in Cambodia: Fight or Fold?
Sales & Marketing Case Study8.95View Details In January 2020, Jai Prakash Chaubey, the managing director of Sarva Pharmaceuticals Private Limited (Sarva), needed to decide whether or not to accept... -
Drug Testing in Nigeria (A)
Global Business Case Study8.95View Details In 1996, a meningitis epidemic swept across Nigeria. Thousands of children were struck and, lacking appropriate medicine, were liable to die from the... -
Upjohn Co.: The Upjohn - Pharmacia Merger
Finance & Accounting Case Study8.95View Details In August 1995, the Upjohn Co. and Pharmacia AB announced a "merger of equals." This case provides background information on the industry, the position... -
Cost Plus Drugs
Strategy & Execution Case Study8.95View Details In September 2022, Mark Cuban Cost Plus Drugs Company CEO Alex Oshmyansky considered the future of the company. Cost Plus Drugs was a retailer for more... -
Merck & Co., Inc.: Addressing Third-World Needs (B)
Strategy & Execution Case Study5.00View Details Supplements Merck & Co., Inc.: Addressing Third-World Needs (A). -
Yunnan Baiyao: Transforming a Chinese State-Owned Enterprise
Global Business Case Study15.05View Details This case tells the story of how Wang Minghui, Chairman of Yunnan Baiyao Group since 1999, transformed a single-product traditional Chinese medicine (TCM)... -
Shanghai Pharmaceuticals
Leadership & Managing People Case Study8.95View Details Shanghai Pharmaceuticals (SPH), a vertically integrated Chinese pharmaceutical conglomerate, was considering its strategic options in the context of a... -
"Doctor My Eyes"--The Acquisition of Bausch & Lomb by Warburg Pincus (A)
Finance & Accounting Case Study8.95View Details In early 2010, senior partners at Warburg Pincus met to review a report on Bausch & Lomb Incorporated, the firm's largest investment at the time. Warburg... -
Public Capital Markets
Finance & Accounting Case Study8.95View Details -
Valuing Celgene's CVR
Finance & Accounting Case Study8.95View Details When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right... -
Graham's Pharmacy: Traditional Care, Modern Solutions
Sales & Marketing Case Study8.95View Details In 2012, Graham's Pharmacy opened to offer more traditional pharmacy services and counselling in contrast to franchise pharmacies. The business was the... -
Sirtris Pharmaceuticals: Living Healthier, Longer (Abridged)
Innovation & Entrepreneurship Case Study8.95View Details Describes a set of key strategic decisions facing the scientific founder and CEO of a promising, early stage bio-pharmaceuticals company. Should the company... -
Purinex, Inc.
Finance & Accounting Case Study8.95View Details In June 2004 Purinex, Inc., a pharmaceutical company with several clinically and commercially promising drugs in development, expected to secure a partnership... -
Roche Holding AG: Funding the Genentech Acquisition
Finance & Accounting Case Study8.95View Details This case examines the decision by the Swiss pharmaceutical Roche Holding AG (Roche) to offer a record $42 billion bond in February 2009. In light of... -
AtHomeCare, Inc.: Health Care Services Rollup
Finance & Accounting Case Study8.95View Details In mid-April 2010, Clark McCullough, a partner at Ardent Capital, reviewed the final investment memorandum concerning a possible $110 million investment... -
Takeda Pharmaceutical Company Limited (A)
Strategy & Execution Case Study8.95View Details This case follows Christophe Weber, President and CEO of Takeda Pharmaceutical Company Limited, a leading pharmaceutical company headquartered in Tokyo,... -
David Pyott: The Battle for Allergan (A)
Strategy & Execution Case Study8.95View Details This case series charts the evolution of the hostile battle for Allergan and its ultimate sale to a white knight, Actavis. David Pyott had been the CEO... -
The Six CEOs of Tyco International Ltd.
Strategy & Execution Case Study8.95View Details In September 2016, Johnson Controls, Inc., completed the acquisition of Tyco International PLC, a $9.9 billion business with operating profits of $884...
-
Reputation and Its Risks
Public relations Magazine ArticleIdentify, quantify, and manage the risks to your company’s reputation long before a problem or crisis strikes. -
Ending the War Between Sales and Marketing
Business communication Magazine ArticleIn many companies, sales forces and marketers feud like Capulets and Montagues—with disastrous results. Here’s how to get them to lay down their swords. -
Who Has the D?: How Clear Decision Roles Enhance Organizational Performance
Decision making and problem solving Magazine ArticleYour organization can become more decisive—and can implement strategy more quickly—if you know where the bottlenecks are and who’s empowered to break through them. -
Sarva Pharmaceuticals in Cambodia: Fight or Fold?
Sales & Marketing Case Study8.95View Details In January 2020, Jai Prakash Chaubey, the managing director of Sarva Pharmaceuticals Private Limited (Sarva), needed to decide whether or not to accept... -
Drug Testing in Nigeria (A)
Global Business Case Study8.95View Details In 1996, a meningitis epidemic swept across Nigeria. Thousands of children were struck and, lacking appropriate medicine, were liable to die from the... -
Upjohn Co.: The Upjohn - Pharmacia Merger
Finance & Accounting Case Study8.95View Details In August 1995, the Upjohn Co. and Pharmacia AB announced a "merger of equals." This case provides background information on the industry, the position... -
Cost Plus Drugs
Strategy & Execution Case Study8.95View Details In September 2022, Mark Cuban Cost Plus Drugs Company CEO Alex Oshmyansky considered the future of the company. Cost Plus Drugs was a retailer for more... -
Graham's Pharmacy: Traditional Care, Modern Solutions, Teaching Note
Sales & Marketing Digital ArticleTeaching Note for case W16637. -
Merck & Co., Inc.: Addressing Third-World Needs (B)
Strategy & Execution Case Study5.00View Details Supplements Merck & Co., Inc.: Addressing Third-World Needs (A).